X0306
4
2014-04-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2014-04-15
4
M
0
1750
28.84
A
160500
D
Common Stock
2014-04-15
4
M
0
5750
32.16
A
166250
D
Common Stock
2014-04-15
4
S
0
2100
60.57
D
164150
D
Common Stock
2014-04-15
4
S
0
2900
61.53
D
161250
D
Common Stock
2014-04-15
4
S
0
1800
62.38
D
159450
D
Common Stock
2014-04-15
4
S
0
700
63.27
D
158750
D
Common Stock
4770
I
401(k)
Common Stock
5568
I
Revocable Trust
Stock Option (right to buy)
28.84
2014-04-15
4
M
0
1750
0.00
D
2017-07-11
Common Stock
1750
0
D
Stock Option (righty to buy)
32.16
2014-04-15
4
M
0
5750
0.00
D
2018-07-23
Common Stock
5750
30500
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $60.57 (range $60.06 to $60.94).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $61.53 (range $61.05 to $61.97).
Open market sales reported on this line occurred at a weighted average price of $62.38 (range $62.00 to $62.84).
Open market sales reported on this line occurred at a weighted average price of $63.27 (range $63.03 to $63.65).
Fully vested.
Kenneth L. Horton, Attorney-In-Fact
2014-04-17